• British Pharmacopoeia Volume III
  • Formulated Preparations: Specific Monographs

Paracetamol Suppositories

scroll to previous hit
scroll to next hit
General Notices
Action and use

Analgesic; antipyretic.

Definition

Paracetamol Suppositories contain Paracetamol in a suitable suppository basis.

The suppositories comply with the requirements stated under Rectal Preparations and with the following requirements.

Content of paracetamol, C8H9NO2

95.0 to 105.0% of the stated amount.

Identification

A. Carry out the method for thin-layer chromatography, Appendix III A, using the following solutions.

(1) Add sufficient methanol to 1 suppository to produce a final solution containing 0.1% w/v of Paracetamol and warm on a water-bath until the suppository has melted. Allow the solution to cool, with occasional stirring, and filter.

(2) 0.1% w/v of paracetamol BPCRS in methanol.

chromatographic conditions

(a) Use as the coating silica gel GF254.

(b) Use the mobile phase as described below.

(c) Apply 10 µL of each solution.

(d) Develop the plate to 15 cm.

(e) After removal of the plate, dry in air and examine under ultraviolet light (254 nm).

mobile phase

1 volume of methanol and 4 volumes of dichloromethane.

confirmation

The principal spot in the chromatogram obtained with solution (1) corresponds to that in the chromatogram obtained with solution (2).

B. Cut into small pieces. To a quantity of the suppositories containing 50 mg of Paracetamol add 1 mL of hydrochloric acid and heat to boiling for 3 minutes; add 10 mL of water and cool. No precipitate is produced. Add 0.05 mL of potassium dichromate solution R1. A violet colour develops which does not change to red.

Tests
Related substances

Carry out the method for liquid chromatography, Appendix III D. Prepare the solutions immediately before use and protect from light.

(1) Cut into small pieces. Dissolve a minimum of 5 suppositories in the minimum volume of ethanol (96%), warming if necessary, and dilute with sufficient water to obtain a solution containing 0.5% w/v of Paracetamol.

(2) Dilute 1 volume of solution (1) to 100 volumes with the mobile phase and dilute 1 volume of the resulting solution to 10 volumes with the mobile phase.

(3) 0.0005% w/v each of 4-aminophenol and paracetamol BPCRS in the mobile phase.

(4) Dilute a 0.005% w/v solution of 4-chloroacetanilide in methanol with the mobile phase to produce a solution containing 0.000005% w/v of 4-chloroacetanilide.

chromatographic conditions

(a) Use a stainless steel column (25 cm × 4.6 mm) packed with octylsilyl silica gel for chromatography (5 µm) (Zorbax Rx C8 is suitable).

(b) Use isocratic elution and the mobile phase described below.

(c) Use a flow rate of 1.5 mL per minute.

(d) Use a column temperature of 35°.

(e) Use a detection wavelength of 245 nm.

(f) Inject 50 µL of each solution.

(g) For solution (1), allow the chromatography to proceed for 12 times the retention time of the principal peak.

mobile phase

250 volumes of methanol containing 1.15 g of a 40% w/v solution of tetrabutylammonium hydroxide, 375 volumes of 0.05m disodium hydrogen orthophosphate and 375 volumes of 0.05m sodium dihydrogen orthophosphate.

system suitability

The test is not valid unless, in the chromatogram obtained with solution (3), the resolution factor between the two principal peaks is at least 4.0.

limits

In the chromatogram obtained with solution (1):

the area of any peak corresponding to 4-aminophenol is not greater than the area of the corresponding peak in the chromatogram obtained with solution (3) (0.1%);

the area of any peak corresponding to 4′-chloroacetanilide is not greater than the area of the principal peak in the chromatogram obtained with solution (4) (10 ppm);

the area of any other secondary peak is not greater than the area of the principal peak in the chromatogram obtained with solution (2) (0.1%);

the sum of the areas of any other secondary peaks is not greater than 5 times the area of the principal peak in the chromatogram obtained with solution (2) (0.5%).

Disregard any peak with an area less than 0.3 times the area of the principal peak in the chromatogram obtained with solution (2) (0.03%).

Assay
For suppositories containing 150 mg or more

To 1 suppository add 30 mL of water and 100 mL of 1m sulfuric acid. Boil under a reflux condenser for 1 hour, cool and add 100 mL of water, 50 g of ice, 50 mL of dilute hydrochloric acid and 0.2 mL of ferroin solution. Titrate with 0.2m ammonium cerium(iv) sulfate VS until a yellow colour is obtained. Each mL of 0.2m ammonium cerium(iv) sulfate VS is equivalent to 15.12 mg of C8H9NO2. Repeat the test using a further 4 suppositories and calculate the average content per suppository from the 5 individual results thus obtained.

For suppositories containing less than 150 mg and more than 60 mg

To 1 suppository add 10 mL of water and 30 mL of dilute sulfuric acid. Boil under a reflux condenser for 1 hour, cool and add 40 mL of water, 40 g of ice, 15 mL of dilute hydrochloric acid and 0.1 mL of ferroin solution. Titrate with 0.1m ammonium cerium(iv) sulfate VS until a yellow colour is obtained. Each mL of 0.1m ammonium cerium(iv) sulfate VS is equivalent to 7.56 mg of C8H9NO2. Repeat the test using a further 4 suppositories and calculate the average content per suppository from the 5 individual results thus obtained.

For suppositories containing 60 mg or less

To 1 suppository add 10 mL of water and 30 mL of dilute sulfuric acid. Boil under a reflux condenser for 1 hour, cool and add 40 mL of water, 40 g of ice, 15 mL of dilute hydrochloric acid and 0.1 mL of ferroin solution. Titrate with 0.025m ammonium cerium(iv) sulfate VS until a yellow colour is obtained. Each mL of 0.025m ammonium cerium(iv) sulfate VS is equivalent to 1.89 mg of C8H9NO2. Repeat the test using a further 4 suppositories and calculate the average content per suppository from the 5 individual results thus obtained.